Evaluation of Synergistic Effect of Continuous Mergers and Acquisitions in Biomedical Enterprises

Take Luye Pharma in China as the Example

DOI

10.2991/aebmr.k.220405.170How to use a DOI?

Keywords

Continuous mergers and acquisitions; synergies; biomedicine; Luye Pharma

Abstract

With the development of economy and the continuous improvement of national health awareness, the scale of China’s biomedical market continues to grow rapidly, becoming an indispensable part of the international biomedical industry. This paper adopts case analysis method to take Luye Pharma of China as an example, and evaluates and studies the collaborative development mode of Luye Pharma acquiring patents through mergers and acquisitions, creating star products and realizing rapid revenue growth, in order to provide experience for the new development mode of mergers and acquisitions of biomedical enterprises.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license.

Download article (PDF)

TY  - CONF
AU  - Qian Liang
AU  - Youmeng Ke
PY  - 2022
DA  - 2022/04/29
TI  - Evaluation of Synergistic Effect of Continuous Mergers and Acquisitions in Biomedical Enterprises
BT  - Proceedings of the 2022 7th International Conference on Social Sciences and Economic Development (ICSSED 2022)
PB  - Atlantis Press
SP  - 1015
EP  - 1019
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220405.170
DO  - 10.2991/aebmr.k.220405.170
ID  - Liang2022
ER  -